Therapeutics R&D Advanced cell / gene-based biopharmaceutical development and CDMO
Patents
| No. | Title | Application No. |
Registration No. |
Application Date |
Country |
|---|---|---|---|---|---|
| 8 | Composition for preventing or treating Duchenne muscular Dystrophy comprising miR-499-5p activator | 10-2021-0186584 | 2021.12.23 | Republic of Korea | |
| 7 | Method for selecting mesenchymal stem cell with improved self-maintenance and mesenchymal stem cells selected by thereof | 10-2020-0169835 | 2020.12.07 | Republic of Korea | |
| 6 | Composition for preventing or treating muscle disease comprising stem cell expressing GRO-α, or GRO-α | 10-2020-0152280 | 2020.11.13 | Republic of Korea | |
| 5 | Pharmaceutical composition for prevention or treatment of muscular disease containing mesenchymal stem cell | 10-2020-0093991 | 2020.07.28 | Republic of Korea | |
| 4 | A stem cell culture method for enhancement of stem cell initial yield | 10-2020-0042893 | 2020.04.08 | Republic of Korea | |
| 3 | A composition for promoting cilia comprising mesenchymal stem cells or culture medium of mesenchymal stem cells | 10-2020-0036871 | 2020.03.26 | Republic of Korea | |
| 2 | Pharmaceutical composition for preventing or treating Charcot-Marie-Tooth disease comprising insulin secreted from mesenchymal stem cells or mesenchymal stem cells | 10-2020-0034461 | 2020.03.20 | Republic of Korea | |
| 1 | Pharmaceutical composition for prevention or treatment of muscular disease containing mesenchymal stem cells or XCL1 | 10-2016-0019927 | 10-1833971 | 2016.02.19 | Republic of Korea |
